Oryzon Genomics (XMAD:ORY) 3-Year EBITDA Growth Rate : 5.30% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Oryzon Genomics 3-Year EBITDA Growth Rate?

Oryzon Genomics's EBITDA per Share for the three months ended in Mar. 2024 was €-0.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was 5.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Oryzon Genomics was 14.90% per year. The lowest was -20.20% per year. And the median was 5.30% per year.

Competitive Comparison of Oryzon Genomics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Oryzon Genomics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oryzon Genomics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's 3-Year EBITDA Growth Rate falls into.

Oryzon Genomics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Oryzon Genomics (XMAD:ORY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Oryzon Genomics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics (XMAD:ORY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (XMAD:ORY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ORYZF:USA ORN:Germany

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.

Oryzon Genomics (XMAD:ORY) Headlines

No Headlines